There’s big news out of the courts when it comes to Xarelto lawsuits.
2015 has seen lots of medication-related court cases to the forefront, and an anticoagulant medication called Xarelto (Rivaroxaban) leads the pack as it’s believed to be responsible for hundreds of cases involving life-threatening internal bleeding an even deadly side effects such as uncontrolled external bleeding and blood clots.
The latest word from the courts is that the federal Xarelto lawsuits (MDL or multi-district litigation cases) are moving forward and a judge in the U.S. District Court in the Eastern District of Louisiana — the court that’s overseeing hundreds of Xarelto cases — recently issued a new ruling concerning plaintiff fact sheets.
2015 Xarelto Court Case Proceedings
The plaintiffs involved in this federal MDL case were instructed on May 4, 2015 to complete a plaintiff fact sheet, which includes information on the individual’s medical history as it relates to their lawsuit. These fact sheets must be verified and submitted to the defense — Xarelto’s manufacturer and its attorneys — within 60 days.
According to court documents, over 430 Xarelto lawsuits have been filed as part of the MDL at the U.S. Federal Court of the Eastern District of Louisiana. In addition, Pennsylvania’s Philadelphia Court of Common Pleas has seen an additional 200 Xarelto cases pending as part of a mass tort program that’s now underway.
What is Xarelto?
Xarelto is a blood thinner medication that’s prescribed to patients suffering from a broad range of conditions, including atrial fibrillation, pulmonary embolism, deep vein thrombosis and stroke.
This blood thinner drug is often prescribed in place of warfarin/coumadin, which requires intensive monitoring to ensure the drug remains in the system at a therapeutic level. Xarelto does not require this intensive monitoring, but unlike coumadin/warfarin, which has an effective antidote, Xarelto has no known antidote — a fact that many patients say they were never informed about.
Xarelto Lawsuits and Deceptive Marketing Claims
In addition, many plaintiffs who’ve filed Xarelto lawsuits also claim that the blood thinner drug was marketed as a safer, better alternative to warfarin/coumadin — marketing that they claim was deceptive and inaccurate due to the prevalence of side effects and the fact that Xarelto lacks an antidote.
Xarelto Side Effects and Bleeding
Xarelto was approved by the U.S. Food and Drug Administration (FDA) in 2011. Xarelto has been associated with a vast array of uncontrolled bleeding and hemorrhaging incidents, such as:
In addition, Xarelto has been associated with deadly blood clots which is perplexing to some since it’s an anticoagulant medication that’s designed to thin the blood and prevent clotting. But some patients have experienced blood clots which are not only dangerous because they can clog regions of the circulatory system, cutting off blood supply to vital organs. But what’s more, these clots are surgically inoperable because an incision would result in uncontrolled and deadly bleeding.
If you or a loved one experienced a blood clot while on Xarelto, you’re encouraged to contact the Meldofsky Law Firm LLC. We’ll work to help you seek out the compensation you’re entitled to receive in order to cover the costs of hospitalization, lost wages, pain and suffering, along with other losses. Simply fill out our form with your details or call us at 877-274-8672.